Our Team

Cara Frosch, MBA, PA

Chief Business Officer
More

Patti Hunker, MS, CCRC, CCRA

Director of Clinical Services
More

Eric English, MS, CBA, RAC

Director, RA/QA Services
More

Gretchen Parker, PhD, RAC, CIP

IRB Co-chair & Board Member, Senior Advisor
More

Allison Detling

Office Administrator
More

Robert Seevers, PhD, CBA

Consultant Advisor,
Former FDA Reviewer
More

Deborah Kurtock Pearl Pathways Senior Clinical Research Advisor

Deborah Kurtock, MT (ASCP)

Senior Clinical Research Advisor
More

Maritza Ward Pearl Pathways Regulatory Advisor

Maritza Ward, RAC

RA/QA Advisor
More

Andrea Mackie

Marketing and Sales Development Manager
More

Olivia Stangret Pearl Pathways_Square

Olivia Draffkorn

Regulatory Analyst
More

Heidi Unger

Senior Regulatory Publication Analyst
More

Ronald Charles

Financial Analyst
More

Ariana Jones

Senior Analyst, RA/QA Services
More

In addition to our core team, Pearl Pathways utilizes a roster of Consultant Advisors possessing deep expertise in the areas of:

  • Pharmacology/Toxicology
  • Formulation Development
  • Analytical Chemistry
  • Preclinical & Nonclinical Development
  • Biostatistics
  • Virology
  • Microbiology
  • Formulation
  • Epidemiology
  • Medical monitoring

Pearl Pathways also strategically partners with external vendors in the following areas to provide services that support every stage of product development:

  • Drug discovery and design
  • Contract drug development and manufacturing
  • Analytical method development, optimization, and validation
  • Pre-formulation and formulation development
  • Pharmacovigilance
  • Bioanalytical testing
  • Data Management, Biostatistics, and Electronic Data Capture (EDC) services for clinical trials
  • Market access and commercialization